A team of university and industry researchers is developing new formulations and manufacturing processes for the messenger RNA (mRNA) delivery systems used in some COVID vaccines. The mRNA-based ...
NMU-Symphony™ is the next generation of the Nutcracker ® Manufacturing Unit, optimized for RNA-based individualized manufacturing of therapeutics The company has successfully completed manufacturing ...
CILA’s proprietary, gene-agnostic platform, CIL-Key™, is designed to enable the development of breakthrough inhaled RNA therapeutics and vaccines for pulmonary diseases — potentially unlocking new ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback